Kristen Ambrose insider trades
Open-market stock purchases and sales by Kristen Ambrose, SVP & Chief Accounting Officer at Vertex Pharmaceuticals Inc / MA, from SEC Form 4 filings since Feb 1, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 28, 2026 | VRTX Vertex Pharmaceuticals Inc / MA | Bought (not open market) | — |
| Feb 26, 2026 | VRTX Vertex Pharmaceuticals Inc / MA | Sold | $173K |
| Feb 25, 2026 | VRTX Vertex Pharmaceuticals Inc / MA | Sold | $108K |
| Feb 24, 2026 | VRTX Vertex Pharmaceuticals Inc / MA | Sold (not open market) | $265K |
| Feb 18, 2026 | VRTX Vertex Pharmaceuticals Inc / MA | Sold | $302K |
| Feb 17, 2026 | VRTX Vertex Pharmaceuticals Inc / MA | Bought (not open market) | — |
| Feb 17, 2026 | VRTX Vertex Pharmaceuticals Inc / MA | Sold (not open market) | $289K |
| Feb 17, 2026 | VRTX Vertex Pharmaceuticals Inc / MA | Sold | $762K |
| Feb 13, 2026 | VRTX Vertex Pharmaceuticals Inc / MA | Sold (not open market) | $679K |
| Feb 11, 2026 | VRTX Vertex Pharmaceuticals Inc / MA | Sold | $634K |
| Feb 10, 2026 | VRTX Vertex Pharmaceuticals Inc / MA | Sold (not open market) | $277K |
| Jan 22, 2026 | VRTX Vertex Pharmaceuticals Inc / MA | Bought (not open market) | — |
| Jan 22, 2026 | VRTX Vertex Pharmaceuticals Inc / MA | Bought (not open market) | — |
Companies traded
- VRTX Vertex Pharmaceuticals Inc / MA: 19 sales, last Aug 28, 2026